Asa Abeliovich

USPTO Granted Patents = 13 (Patent Applications = 19)

EPO Patents = 1 (Patent Applications = 13)

Average Co-Inventor Count = 3.3

ph-index = 4

Forward Citations = 29(Granted Patents)

Company Filing History:

11 out of 11

Prevail Therapeutics, Inc.

Years Active: 2016-2024

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12049626 - Gene therapy for neurodegenerative disorders (2024-07-30),

2. 11999974 - Gene therapies for lysosomal disorders (2024-06-04),

3. 11993790 - Gene therapies for lysosomal disorders (2024-05-28),

4. 11903985 - Gene therapies for lysosomal disorders (2024-02-20),

5. 11807849 - Gene therapies for lysosomal disorders (2023-11-07),

6. 11802294 - Gene therapies for lysosomal disorders (2023-10-31),

7. 11661585 - Gene therapies for lysosomal disorders (2023-05-30),

8. 11655460 - Gene therapies for lysosomal disorders (2023-05-23),

9. 11470827 - Transgenic mice expressing human TREM proteins and methods of use thereof (2022-10-18),

10. 11060113 - Gene therapies for lysosomal disorders (2021-07-13),

11. 10837028 - Gene therapies for lysosomal disorders (2020-11-17),

12. 10689625 - Gene therapies for lysosomal disorders (2020-06-23),

13. 9290759 - Optimized miRNA constructs (2016-03-22),

Title: The Innovative Mind of Asa Abeliovich

Introduction: Asa Abeliovich is a pioneering inventor based in New York, NY, known for her groundbreaking contributions to the field of biotechnology and medical research.

Latest Patents: Asa Abeliovich holds several patents related to novel treatments for neurodegenerative diseases, including a recent patent for a revolutionary gene therapy targeting Alzheimer's disease.

Career Highlights: With a background in neuroscience and genetics, Asa Abeliovich has dedicated her career to developing innovative solutions for complex medical conditions. Her work has been recognized for its potential to transform the way we approach neurological disorders.

Collaborations: Throughout her career, Asa Abeliovich has collaborated with leading researchers, medical professionals, and biotech companies to further the development and implementation of her inventions. Her collaborative spirit has been instrumental in advancing the field of neurology.

Conclusion: Asa Abeliovich's relentless pursuit of innovation and her passion for improving the lives of those affected by neurodegenerative diseases have solidified her reputation as a trailblazing inventor in the medical community. Her work continues to inspire and pave the way for future advancements in the field.

This text is generated by artificial intelligence and may not be accurate.